Generic Fluticasone + Salmeterol (Fluticasone + Salmeterol )

Product Identification

What Is Generic Advair Rotacaps?

Generic Advair Rotacaps are individually sealed dry-powder capsules, each containing a precisely measured dose of fluticasone propionate and salmeterol. A patient loads one capsule into a Rotahaler device, which punctures the shell and releases the powder for inhalation. Each capsule is single-use — unlike multi-dose devices such as Advair Diskus, which contains 60 pre-metered doses in a single inhaler.

The product is manufactured by Cipla Ltd. and is widely distributed outside the United States under the name Seroflo Rotacaps. It contains the same two active pharmaceutical ingredients as Advair Diskus at clinically similar strengths. Pharmacokinetic studies have evaluated Rotacaps/Rotahaler delivery versus Diskus delivery and found generally comparable systemic exposure, with some variability depending on the specific Rotahaler device model used and the patient's inspiratory airflow rate.

Because this product is manufactured outside the U.S. and has not gone through the FDA approval process, it is regulated as an international generic. Patients should understand this distinction and discuss it with their prescribing physician before initiating therapy.

How It Differs from Fluticasone-Only Inhalers

Flovent Diskus and Flovent HFA contain only fluticasone propionate — no salmeterol. They treat asthma but are not indicated for COPD and do not provide the bronchodilator effect that salmeterol adds. Generic Advair Rotacaps are a fixed-dose combination product with two active ingredients, which changes both how the product works and its applicable warnings — particularly the LABA-related boxed warning described in the Warnings section below.

Active Ingredients, Strengths, and Formulation

Fluticasone Propionate — the corticosteroid component

Fluticasone propionate is a synthetic corticosteroid. It reduces inflammation inside the airways — decreasing swelling, mucus production, and the hypersensitivity of the airways to asthma triggers. Its benefits build gradually over days and weeks; it does not provide immediate relief of symptoms.

In Generic Advair Rotacaps, fluticasone propionate is available at three strengths: 100 mcg, 250 mcg, and 500 mcg per capsule.

Salmeterol — the long-acting bronchodilator component

Salmeterol is a long-acting beta₂-adrenergic agonist (LABA). It relaxes the smooth muscle surrounding the airways, keeping them wider and making breathing easier. Its effect lasts approximately 12 hours per dose, which is why the medication is taken twice daily. Salmeterol carries an important boxed warning related to asthma-related death risk — see the Warnings section below for full details.

The salmeterol dose is fixed at 50 mcg per capsule across all three available strengths. Only the fluticasone component varies.

Formulation and Excipients

The active ingredients are blended with lactose monohydrate as a carrier to allow fine-particle delivery deep into the lungs. Patients with a known severe allergy to milk proteins should not use this product. A digestive intolerance to lactose is different from a milk protein allergy — but patients with any milk-related concerns should confirm suitability with their doctor before use.

What Is Generic Advair Rotacaps Used For?

Asthma — Long-Term Maintenance

Fluticasone propionate and salmeterol inhalation powder is indicated for the twice-daily maintenance treatment of asthma in patients 4 years and older who are not adequately controlled on an inhaled corticosteroid alone, or whose disease severity warrants initiation of treatment with both an ICS and a LABA.

COPD — Long-Term Maintenance

The 250 mcg / 50 mcg strength is used for the twice-daily maintenance treatment of airflow obstruction in adults with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Only the 250/50 mcg strength is documented for COPD in the reference product labeling. The 100/50 and 500/50 mcg strengths are used for asthma management.

What This Product Is Not For

• Acute rescue during asthma attacks or COPD flare-ups
• Primary treatment for patients whose asthma is already adequately controlled on an inhaled corticosteroid alone
• Treatment of acute bronchospasm in any clinical setting

How Generic Advair Rotacaps Work

The two active ingredients address different aspects of airway disease simultaneously.

Fluticasone Propionate — Reducing Inflammation

Fluticasone propionate binds to glucocorticoid receptors in airway cells. This reduces the production and release of inflammatory chemicals — including cytokines, histamines, and leukotrienes — that cause airway swelling, mucus overproduction, and hypersensitivity to triggers. By consistently reducing this inflammation over time, the medication helps prevent asthma attacks and slows the progressive airflow limitation seen in COPD.

Salmeterol — Opening the Airways

Salmeterol binds selectively to beta₂-adrenergic receptors on the smooth muscle cells that surround the airways. When these receptors are activated, the smooth muscle relaxes and the airway widens. Salmeterol's chemical structure anchors it to the receptor region, producing a prolonged effect lasting approximately 12 hours per dose. This distinguishes salmeterol from short-acting bronchodilators such as albuterol, which last only 4–6 hours.

Why the Combination Matters

Inflammation causes underlying damage and airway hypersensitivity; bronchoconstriction causes the immediate obstruction that restricts airflow. Treating both simultaneously in a single inhalation addresses more of the disease process than either agent does alone. Current clinical guidelines recommend combination ICS/LABA therapy for moderate-to-severe asthma and for symptomatic COPD not controlled by a single agent.

Pharmacokinetics — How the Body Handles This Medicine

Fluticasone Propionate

After inhalation, fluticasone propionate is absorbed primarily through the lungs. A portion of the inhaled dose is swallowed but is poorly absorbed from the gastrointestinal tract due to low oral bioavailability and extensive first-pass liver metabolism. The systemic bioavailability of fluticasone propionate via the Diskus device averages approximately 18% in healthy volunteers. Rotacaps/Rotahaler delivery has been found to produce comparable to approximately 1.2–1.9-fold greater fluticasone systemic exposure compared with the Diskus, depending on the specific Rotahaler device model and the patient's inspiratory airflow rate. Fluticasone propionate is metabolized primarily by the liver enzyme CYP3A4 — which is why strong inhibitors of that enzyme can significantly raise fluticasone blood levels and increase the risk of corticosteroid-related side effects.

Salmeterol

Salmeterol acts locally within the lungs. It is also metabolized by CYP3A4 in the liver. Systemic absorption is minimal at recommended doses, which is why cardiovascular effects are much lower than those seen with older non-selective beta-agonists. At higher-than-prescribed doses or in combination with certain interacting medicines, these cardiovascular effects can become clinically significant.

Dosage and Administration

The standard regimen is one rotacap (one inhalation) twice daily, approximately 12 hours apart — typically morning and evening. The appropriate strength is selected by the prescribing physician based on diagnosis, symptom severity, current therapy, and patient age.

How to Use Generic Advair Rotacaps

1. Remove one rotacap from the blister pack. Do not swallow it — it is designed for inhalation only.
2. Open the Rotahaler device by twisting the mouthpiece and place the rotacap into the capsule chamber with the printed end facing up.
3. Close the Rotahaler firmly — this punctures the capsule and releases the powder inside.
4. Breathe out gently away from the device. Do not breathe into the mouthpiece.
5. Place the mouthpiece in your mouth, seal your lips around it, and inhale deeply and steadily.
6. Hold your breath for approximately 10 seconds — or as long as is comfortable — then exhale slowly.
7. Open the device and check that the capsule is empty. If visible powder remains, close the device and repeat the inhalation.
8. Rinse your mouth with water and spit — do not swallow. Do this after every use to reduce the risk of oral thrush (candidiasis) caused by residual fluticasone in the mouth and throat.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is close to the time for your next scheduled dose, skip the missed dose entirely and continue your regular morning/evening schedule. Do not take two doses in a single session to compensate — a double dose does not improve symptom control and increases the risk of side effects, particularly from the salmeterol component.

This product needs to be taken consistently every day — including days when you feel well — to provide ongoing protective benefit. Regularly missing doses may reduce its effectiveness over time.

Overdose

Using more than the prescribed dose may produce signs of excessive beta₂-adrenergic stimulation from the salmeterol component — including rapid or irregular heartbeat, chest pain, tremor, headache, dizziness, and muscle cramps — as well as effects from excess corticosteroid exposure such as fluid retention, raised blood sugar, and suppressed adrenal function.

Important Warnings and Precautions

Additional Warnings

• Not for acute rescue. This product will not stop a breathing emergency. Always keep a short-acting rescue inhaler available at all times.
• Do not add a second LABA. Using another long-acting beta₂-agonist alongside this product (such as formoterol or indacaterol) creates a risk of salmeterol overdose and is not appropriate.
• Oral candidiasis (thrush). Inhaled fluticasone can cause a fungal infection of the mouth and throat. Rinsing the mouth after every use substantially reduces this risk.
• Increased infection risk. Inhaled corticosteroids can suppress local immune defenses. Avoid exposure to chickenpox and measles in unvaccinated patients. If significant exposure occurs, consult a physician promptly.
• Adrenal suppression. High doses or long-term use may reduce the body's ability to produce its own cortisol. Patients switching from high-dose oral corticosteroids are at particular risk.
• Bone density. Long-term inhaled corticosteroid use may reduce bone mineral density. Patients at risk for osteoporosis should discuss monitoring with their doctor.
• Eye effects. Glaucoma and cataracts have been reported with prolonged inhaled corticosteroid use. Report any new eye symptoms to your doctor.
• Cardiovascular effects. Salmeterol can cause a transient increase in heart rate and blood pressure. Use with caution in patients with cardiovascular disease, arrhythmia, or hypertension.
• Metabolic effects. Beta₂-agonists can lower blood potassium (hypokalemia) and raise blood sugar (hyperglycemia). Monitor accordingly in patients with diabetes or those taking diuretics.
• Paradoxical bronchospasm. Rarely, inhaled medicines can cause immediate airway tightening. If breathing worsens right after using this product, stop use and seek urgent medical attention.
• Growth in children. Inhaled corticosteroids may slow growth velocity in pediatric patients. Growth should be measured regularly during long-term therapy.

Contraindications

Do not use Generic Advair Rotacaps if you have:

• A need for acute bronchospasm relief — including acute severe asthma attacks and life-threatening COPD exacerbations.
• A known severe hypersensitivity to milk proteins. The formulation contains lactose derived from milk.
• A known hypersensitivity to fluticasone propionate, salmeterol, or any other ingredient in the formulation.

Side Effects

Like all medicines, fluticasone/salmeterol rotacaps can cause side effects. Not everyone experiences them. The severity and frequency vary by dose, duration of use, and individual patient factors.

Common Side Effects (reported in ≥3% of patients in clinical trials)

• Upper respiratory tract infections
• Pharyngitis (sore throat)
• Hoarseness or voice changes (dysphonia)
• Oral candidiasis (thrush)
• Bronchitis
• Cough
• Headache
• Nausea (reported in asthma trials)

Less Common Side Effects

• Throat irritation
• Musculoskeletal pain
• Tremor
• Palpitations
• Dizziness
• Sinus headache
• Fluid retention
• Raised blood sugar (hyperglycemia)

Serious Adverse Reactions — Seek Medical Attention

• Pneumonia — particularly in patients with COPD
• Severe allergic reactions including anaphylaxis and angioedema (swelling of the face, lips, tongue, or throat)
• Paradoxical bronchospasm (sudden worsening of breathing after inhalation)
• Adrenal insufficiency
• Significant hypokalemia (dangerously low blood potassium)
• Increased intraocular pressure or glaucoma
• Laryngeal spasm, irritation, or stridor

Drug, Food, and Supplement Interactions

Tell your doctor and pharmacist about every prescription medicine, over-the-counter product, supplement, and herbal preparation you take before starting Generic Advair Rotacaps. The most clinically important interactions are listed below.

This list does not cover every possible interaction. Herbal preparations — particularly St. John's Wort, which affects the CYP3A4 enzyme — may also be relevant. Always provide your complete medication list to your pharmacist.

Special Populations

Pregnancy

There are limited human data on the use of fluticasone propionate/salmeterol during pregnancy. Animal studies with salmeterol have shown reproductive effects at high doses. Poorly controlled asthma itself poses significant risks during pregnancy — including reduced fetal oxygen supply, preterm birth, and low birth weight. The prescribing decision should weigh these risks carefully. Pregnant patients should not stop asthma medication without medical guidance.

Breastfeeding

It is not known whether fluticasone propionate or salmeterol is excreted in human breast milk. Both drugs are excreted in animal breast milk at measurable levels. If this medication is needed during breastfeeding, the benefit-risk balance should be discussed with your doctor.

Children

The reference U.S. prescribing information supports use in children with asthma from age 4 years onward, at the 100/50 mcg strength only for children aged 4–11 years. Children 12 and older may use higher strengths as prescribed by their physician. Growth velocity should be monitored regularly in all pediatric patients using inhaled corticosteroids on a long-term basis. If a child's growth appears to slow, the physician should reassess the treatment dose and plan.

Older Adults

Older patients may be more susceptible to corticosteroid-associated side effects such as bone loss, cataracts, glaucoma, and reduced immune function. No specific dose adjustment is generally required, but more frequent monitoring is appropriate — particularly for bone density and intraocular pressure in patients receiving long-term therapy.

Kidney Problems

No specific dosage adjustment is generally required for patients with renal impairment based on currently available evidence.

Liver Problems

Because fluticasone propionate is primarily metabolized in the liver via CYP3A4, patients with significant hepatic impairment may have higher-than-expected fluticasone blood levels. These patients should be monitored for signs of systemic corticosteroid effects, including adrenal suppression, cushingoid features, or raised blood sugar.

Storage and Handling

• Store at room temperature, protected from heat, moisture, and direct light.
• Keep rotacaps sealed in the original blister packaging until you are ready to use them. Once a capsule is removed from its blister, use it immediately — do not store an opened capsule for later.
• Do not use a capsule that is damaged, already pierced, or appears wet.
• Keep the Rotahaler device clean and dry between uses.
• Keep all medicines out of the reach of children.
• Dispose of used capsules, empty blister strips, and expired medicine in accordance with your local waste disposal guidelines. Do not flush medicines unless local disposal programs specifically instruct this.

Ordering Generic Advair Rotacaps Through RiteDrugstore

How to Submit Your Prescription

You can submit a new prescription or request a transfer from your current pharmacy through the RiteDrugstore prescription portal. Upload a copy of your written prescription, or have your prescriber send it directly to our pharmacy team.

What Happens After You Order

Our pharmacy team reviews every prescription before dispensing. If there are any questions about your order — including dosage, strength, or quantity — a team member may contact you or your prescriber before the order is processed and shipped.

Refills

Refill requests can be submitted through your RiteDrugstore account. Plan your refills in advance. This is a maintenance medication — interruptions in therapy can affect symptom control and should be avoided.

Questions?

Contact our pharmacy team directly if you have questions about this product, your prescription, or your order status. We are available to assist before and after purchase.

Understanding the Product Options

Several products share fluticasone propionate and salmeterol as active ingredients but differ meaningfully in device type, manufacturer, and regulatory status.

The Rotacaps/Rotahaler system delivers one dose per capsule. Some patients find this easier to manage than a pre-loaded multi-dose device; others prefer the convenience of not loading capsules individually. Device preference can affect real-world adherence — discuss options with your prescriber if you are uncertain which delivery system is right for you.

Frequently Asked Questions

What are the active ingredients in Generic Advair Rotacaps?

Generic Advair Rotacaps contain two active ingredients: fluticasone propionate (an inhaled corticosteroid) and salmeterol xinafoate (a long-acting beta₂-agonist). Fluticasone reduces airway inflammation; salmeterol keeps the airways relaxed and open for approximately 12 hours per dose. Both are needed for the combination to be effective.

What strengths are available?

Three strengths are available: 100 mcg / 50 mcg, 250 mcg / 50 mcg, and 500 mcg / 50 mcg (fluticasone propionate / salmeterol per capsule). The salmeterol dose remains constant at 50 mcg. Your prescriber will select the appropriate strength based on your diagnosis, current therapy, and symptom severity.

Is this the same product as Advair Diskus?

It contains the same two active ingredients in the same strengths, but it is not the same physical product. Advair Diskus is a branded, FDA-approved multi-dose inhaler made by GlaxoSmithKline. Generic Advair Rotacaps are single-dose capsules manufactured by Cipla Ltd. in India, used with a separate Rotahaler device, and are not FDA-approved. The only FDA-approved substitutable generic of Advair Diskus is Wixela Inhub (Mylan/Viatris).

Can I use this product during a sudden asthma attack?

No. Generic Advair Rotacaps are a maintenance medication designed to prevent symptoms over time — not to treat a sudden attack. During an acute asthma attack, use your fast-acting rescue inhaler (such as albuterol or salbutamol). If your rescue inhaler does not provide adequate relief, seek emergency medical care immediately.

How often should I use this medication?

One inhalation twice daily, approximately 12 hours apart — typically morning and evening. Do not use it more often than prescribed. Do not skip doses even on days when you feel well. Consistent daily use is what provides the ongoing protective benefit.

Why do I need to rinse my mouth after each use?

Inhaled corticosteroids such as fluticasone propionate can deposit in the mouth and throat during inhalation. This residue can promote the growth of Candida albicans — the fungus that causes oral thrush (white patches, soreness, or difficulty swallowing). Rinsing with water and spitting after every use removes most of the residue and substantially lowers this risk. Do not swallow the rinse water.

Can I swallow the rotacap capsule?

No. The rotacap must be loaded into the Rotahaler device for inhalation. If swallowed, the medicine will not reach the lungs where it is needed. Never place a rotacap in your mouth to swallow it.

Is this product FDA-approved?

No. This product is not FDA-approved. It is an internationally manufactured generic produced by Cipla Ltd. in India. The FDA-approved branded product for the same active ingredients is Advair Diskus (GlaxoSmithKline). The only FDA-approved substitutable generic of Advair Diskus currently available in the U.S. is Wixela Inhub (Mylan/Viatris). Patients and prescribers should be aware of this regulatory distinction.

Who manufactures Generic Advair Rotacaps?

Cipla Ltd., headquartered in Mumbai, India. Cipla is one of the world's largest generic pharmaceutical manufacturers. This product is produced and distributed internationally under the name Seroflo Rotacaps.

Does this product contain lactose?

Yes. The formulation contains lactose monohydrate as a carrier excipient, which is standard for dry-powder inhalers of this type. Patients with a known severe allergy to milk proteins should not use this product. Digestive lactose intolerance is generally different from a milk protein allergy — but if you have any milk-related sensitivities, confirm suitability with your doctor before use.

What should I do if my breathing worsens while using this product?

Contact your doctor promptly. If breathing difficulty is severe or does not respond to your rescue inhaler, seek emergency medical attention. A sudden worsening immediately after using the inhaler may indicate paradoxical bronchospasm — a rare reaction requiring the medicine to be stopped and medical evaluation. A gradual worsening of control over time may indicate your asthma or COPD needs a different treatment plan.

Can children use this medicine?

The U.S. reference prescribing information supports use in children with asthma from age 4 years onward. Children aged 4–11 years should use the 100/50 mcg strength only. Children 12 and older may be prescribed higher strengths. Growth should be monitored regularly in all children using inhaled corticosteroids long-term. A pediatrician should assess whether this specific product is appropriate for any individual child.

Medical Information Sources

The medical information on this page is drawn from the following authoritative sources. These references were used to verify active ingredients, indications, dosage, warnings, contraindications, interactions, and pharmacokinetics.

1. U.S. Food and Drug Administration / DailyMed. ADVAIR DISKUS (fluticasone propionate and salmeterol) inhalation powder — Full Prescribing Information. U.S. National Library of Medicine. View on DailyMed ↗
2. U.S. Food and Drug Administration. ADVAIR DISKUS Prescribing Information — 2019 label. View FDA label PDF ↗
3. U.S. Food and Drug Administration / DailyMed. Wixela Inhub (fluticasone propionate and salmeterol inhalation powder) — FDA-approved generic prescribing information. View on DailyMed ↗
4. Ng D, et al. Clinical Bioequivalence of Wixela Inhub and Advair Diskus in Adults With Asthma. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2020. PMID: 32109139.
5. Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler in patients with asthma. Respiratory Medicine. 2016. PMID: 25035069.
6. Assessment of FSC 50/250 mcg Rotacaps/Rotahaler versus Diskus in COPD patients. Peer-reviewed clinical study. PMID: 28115223.
7. GlaxoSmithKline. FSC Rotacaps/Rotahaler pharmacokinetic comparison study — NCT01540708. ClinicalTrials.gov. View on ClinicalTrials.gov ↗
8. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention — 2024 Update. View GINA Report ↗
9. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Prevention, Diagnosis and Management of COPD — 2024 Report. View GOLD Report ↗